Insulet Corp (PODD) stock
PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3045% below fair value
$152.48+3.19 (+2.14%)
Close on Nov 13, 2026Market cap $10.58BP/E 24.8Yield –
Insulet revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Insulet's revenue for the twelve months ending Sep 30, 2026 was $3.19B, up 26.5% year over year. For fiscal 2025 it was $2.71B, up 30.7% from the year before. Over ten years it grew 26.2% a year on average. The highest annual figure on record is $2.71B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.71B | +30.7% |
| FY2024 | Dec 31, 2024 | $2.07B | +22.1% |
| FY2023 | Dec 31, 2023 | $1.70B | +30.0% |
| FY2022 | Dec 31, 2022 | $1.31B | +18.8% |
| FY2021 | Dec 31, 2021 | $1.10B | +21.5% |
| FY2020 | Dec 31, 2020 | $904.40M | +22.5% |
| FY2019 | Dec 31, 2019 | $738.20M | +30.9% |
| FY2018 | Dec 31, 2018 | $563.80M | +21.6% |
| FY2017 | Dec 31, 2017 | $463.80M | +26.4% |
| FY2016 | Dec 31, 2016 | $366.99M | +39.1% |
| FY2015 | Dec 31, 2015 | $263.89M | +14.1% |
| FY2014 | Dec 31, 2014 | $231.32M | -6.4% |
| FY2013 | Dec 31, 2013 | $247.08M | +16.9% |
| FY2012 | Dec 31, 2012 | $211.37M | +38.8% |
| FY2011 | Dec 31, 2011 | $152.26M | +57.0% |
| FY2010 | Dec 31, 2010 | $96.97M | +46.8% |
| FY2009 | Dec 31, 2009 | $66.03M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $842.00M | +19.2% |
| Q2 FY2026 | Jun 30, 2026 | $801.70M | +23.5% |
| Q1 FY2026 | Mar 31, 2026 | $761.70M | +33.9% |
| Q4 FY2025 | Dec 31, 2025 | $783.80M | +31.2% |
| Q3 FY2025 | Sep 30, 2025 | $706.30M | +29.9% |
| Q2 FY2025 | Jun 30, 2025 | $649.10M | +32.9% |
| Q1 FY2025 | Mar 31, 2025 | $569.00M | +28.8% |
| Q4 FY2024 | Dec 31, 2024 | $597.50M | +17.2% |
| Q3 FY2024 | Sep 30, 2024 | $543.90M | +25.7% |
| Q2 FY2024 | Jun 30, 2024 | $488.50M | +23.2% |
| Q1 FY2024 | Mar 31, 2024 | $441.70M | +23.3% |
| Q4 FY2023 | Dec 31, 2023 | $509.80M | +37.9% |
| Q3 FY2023 | Sep 30, 2023 | $432.70M | +27.0% |
| Q2 FY2023 | Jun 30, 2023 | $396.50M | +32.4% |
| Q1 FY2023 | Mar 31, 2023 | $358.10M | +21.2% |
| Q4 FY2022 | Dec 31, 2022 | $369.70M | +20.1% |
| Q3 FY2022 | Sep 30, 2022 | $340.80M | +23.7% |
| Q2 FY2022 | Jun 30, 2022 | $299.40M | +13.8% |
| Q1 FY2022 | Mar 31, 2022 | $295.40M | +17.1% |
| Q4 FY2021 | Dec 31, 2021 | $307.70M | +25.0% |
| Q3 FY2021 | Sep 30, 2021 | $275.60M | +17.8% |
| Q2 FY2021 | Jun 30, 2021 | $263.20M | +16.3% |
| Q1 FY2021 | Mar 31, 2021 | $252.30M | +27.4% |
| Q4 FY2020 | Dec 31, 2020 | $246.10M | +17.5% |
| Q3 FY2020 | Sep 30, 2020 | $234.00M | +21.8% |
| Q2 FY2020 | Jun 30, 2020 | $226.30M | +27.8% |
| Q1 FY2020 | Mar 31, 2020 | $198.00M | +24.1% |
| Q4 FY2019 | Dec 31, 2019 | $209.40M | +27.0% |
| Q3 FY2019 | Sep 30, 2019 | $192.10M | +27.1% |
| Q2 FY2019 | Jun 30, 2019 | $177.10M | +42.6% |
| Q1 FY2019 | Mar 31, 2019 | $159.60M | +29.1% |
| Q4 FY2018 | Dec 31, 2018 | $164.90M | +26.3% |
| Q3 FY2018 | Sep 30, 2018 | $151.10M | +24.1% |
| Q2 FY2018 | Jun 30, 2018 | $124.20M | +13.2% |
| Q1 FY2018 | Mar 31, 2018 | $123.60M | +21.5% |
| Q4 FY2017 | Dec 31, 2017 | $130.52M | +26.0% |
| Q3 FY2017 | Sep 30, 2017 | $121.78M | – |
| Q2 FY2017 | Jun 30, 2017 | $109.76M | – |
| Q1 FY2017 | Mar 31, 2017 | $101.71M | – |
| Q4 FY2016 | Dec 31, 2016 | $103.58M | – |
See a number that looks wrong?